Previous studies have resulted in the classification of << amezinium >> as a selective inhibitor of neuronal monoamine oxidase (MAO), because it is a much more potent [[ MAO ]] inhibitor in intact tissues, in which it is accumulated in noradrenergic neurones by uptake1, than in tissue homogenates.